Skip Over Navigation Links

NIH Research Matters

October 31, 2011

Perinatal Antidepressant May Affect Brain Development

Rats exposed to an antidepressant just before and after birth had altered behaviors and substantial brain abnormalities. The findings raise questions about how perinatal antidepressants might influence brain development in people.

Photos showing cross sections of normal brain on left and abnormal brain on right.

The part of the brain that connects the left and right hemispheres shows abnormalities (right) in rats that received an antidepressant during a critical period around the time of birth.Source: Dr. Rick C.S. Lin, University of Mississippi Medical Center.

Serotonin—a chemical messenger in the brain—plays an important role in brain development. Antidepressants called selective serotonin reuptake inhibitors (SSRIs) work by boosting serotonin activity in the brain. However, recent studies have found associations between women taking SSRIs during pregnancy and potential development problems in their offspring, including an increased risk for autism.

A team led by Dr. Rick Lin of the University of Mississippi Medical Center, Jackson, used rats as a model to investigate the effects of SSRIs on brain development. The scientists gave citalopram, an SSRI, to male and female rat pups prenatally and postnatally and examined their brains and behavior as they grew up. The work was supported by several NIH institutes, including the National Institute of Mental Health (NIMH). Results appeared online before print on October 24, 2011, in the Proceedings of the National Academy of Sciences.

The researchers found that long-distance connections between the 2 hemispheres of the brain showed stunted growth and degeneration. The animals also became excessively fearful when faced with new situations and failed to play normally with peers—behaviors reminiscent of autism.

The abnormalities were more pronounced in male than female rats, just as autism affects 3-4 times more boys than girls. Male, but not female, SSRI-exposed rat pups abnormally froze when they heard an unfamiliar tone and balked at exploring their environment in the presence of unfamiliar objects or scents. These behaviors persisted into adulthood. The male pups were also more likely to shun normal juvenile play behavior.

The brains of perinatally exposed animals showed evidence of neurons firing out of sync and other electrophysiological abnormalities. A key brain serotonin circuit called the raphe system showed evidence of stunted development. The raphe system is known to shape the developing brain during the critical period when the rat pups were exposed to the drug. The researchers also discovered problems in the structure responsible for communications between the brain's left and right hemispheres, called the corpus collosum. This damage was 3 times worse in male than in female pups.

“Our findings underscore the importance of balanced serotonin levels—not too high or low—for proper brain maturation,” Lin says.

“While one must always be cautious extrapolating from medication effects in rats to medication effects in people, these new results suggest an opportunity to study the mechanisms by which antidepressants influence brain and behavioral development,” says NIMH Director Dr. Thomas R. Insel. “These studies will help to balance the mental health needs of pregnant mothers with possible increased risk to their offspring.”

Related Links:

Contact Us

E-mail: nihresearchmatters@od.nih.gov

Mailing Address:
NIH Research Matters
Bldg. 31, Rm. 5B64A, MSC 2094
Bethesda, MD 20892-2094

About NIH Research Matters

Editor: Harrison Wein, Ph.D.
Assistant Editors: Vicki Contie, Carol Torgan, Ph.D.

NIH Research Matters is a weekly update of NIH research highlights from the Office of Communications and Public Liaison, Office of the Director, National Institutes of Health.

ISSN 2375-9593

This page last reviewed on December 4, 2012

Social Media Links